# A Trial Investigating the Absolute Bioavailability of Insulin Degludec in Healthy Subjects

> **NCT01623375** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 18 (actual)

## Conditions studied

- Diabetes
- Healthy

## Interventions

- **DRUG:** insulin degludec
- **DRUG:** insulin degludec

## Key facts

- **NCT ID:** NCT01623375
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2015-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01623375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01623375, "A Trial Investigating the Absolute Bioavailability of Insulin Degludec in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01623375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*